Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2005Clinical and Vaccine ImmunologyOpen Access

Optimization and Validation of a Multiplexed Luminex Assay To Quantify Antibodies to Neutralizing Epitopes on Human Papillomaviruses 6, 11, 16, and 18

View Full Paper
Ask AI
Bookmark
Share

Authors

DDDennis DiasMerck & Co., Inc., Rahway, NJ, USA (United States)JDJeff Van DorenMerck & Co., Inc., Rahway, NJ, USA (United States)SSSonela A. SchlottmannMerck & Co., Inc., Rahway, NJ, USA (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dias et al. (2005) studied this question.

synapsesocial.com/papers/6a1bda52d54006be995f1bd1https://doi.org/10.1128/cdli.12.8.959-969.2005
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 111990 · 118 citations
  2. 2Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective1995 · 3,437 citations
  3. 3Human Papillomavirus Testing for Triage of Women With Cytologic Evidence of Low-Grade Squamous Intraepithelial Lesions: Baseline Data From a Randomized Trial2000 · 444 citations
  4. 4Simultaneous Quantitation of Antibodies to Neutralizing Epitopes on Virus-Like Particles for Human Papillomavirus Types 6, 11, 16, and 18 by a Multiplexed Luminex Assay2003 · 277 citations
  5. 5Seroepidemiology of Infection with Human Papillomavirus 16, in Men and Women Attending Sexually Transmitted Disease Clinics in the United States2004 · 62 citations